This is a temporarily removed expert consensus decision pathway regarding antithrombotic therapy in patients with AF/VTE undergoing PCI or with ASCVD.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Kumbhani et al. (2020) studied this question. The 2020 ACC Expert Consensus Decision Pathway provides guidance for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing PCI or with ASCVD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: